We are studying a new treatment combining durvalumab with etoposide and platinum for patients with advanced large-cell neuroendocrine carcinomas of the lung. The goal is to evaluate its effectiveness and safety compared to standard treatments.
Health conditions and diseases that the clinical trial is designed to study and treat.
Large-Cell Neuroendocrine Carcinoma of the lung is a rare and aggressive type of lung cancer that originates from neuroendocrine cells, often leading to symptoms like persistent cough, chest pain, and difficulty breathing.
Locally advanced (Stage III) or metastatic (Stage IV) lung cancer refers to cancer that has spread beyond the lungs to nearby tissues or other parts of the body, often requiring systemic treatment options.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.